Compare AdaptHealth Corp (AHCO) vs Hershey Co (HSY) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
AdaptHealth Corp vs Hershey Co — how do they compare? AdaptHealth Corp trades at $10.06 (market cap $1.38B), while Hershey Co trades at $175.61 (market cap $35.69B). The key difference: Hershey Co is far larger — about 25.9× AdaptHealth Corp's market cap, and Hershey Co pays a 3.3% dividend while AdaptHealth Corp pays none. Which is the better fit depends on your goals.
| AHCO | HSY | |
|---|---|---|
Market Cap | $1.38B | $35.69B |
Sector | Health | Consumer Staples |
52-Week High | $13.38 | $236.28 |
52-Week Low | $8.68 | $161.95 |
Enterprise Value | $3.33B | $40.49B |
Dividend Yield | — | 3.3% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AdaptHealth (AHCO) trades at $10.27, down 4.55% today, with neutral technical signals and mixed fundamental performance. The company reported Q1 2026 earnings miss with negative EPS of -$0.06 versus $0.0125 expected, continuing a pattern of recent quarterly misses. Despite revenue growth to $3.3B projected for 2026, net income remains negative with -2.43% margin. Analyst consensus remains bullish with 75% buy ratings and $14.80 price target, representing 44% upside potential from current levels.
The investment case balances strong analyst support and reasonable valuation (P/S 0.42, EV/EBITDA 7.17) against persistent profitability challenges. Recent refinancing improves financial flexibility, but execution on cost controls and margin improvement remains critical. The stock offers significant upside if management can translate revenue growth into sustainable profitability, though current negative earnings trend presents near-term headwinds.
Hershey (HSY) trades at $175.95, down 3.4% over the past day, with a bearish technical signal but strong recent earnings beats. The stock shows a high P/E ratio of 33.06 and a net income margin of 9.12%, supported by consistent cash flow from operations of $2.28B in 2025. Recent corporate actions include a $1.45 dividend and executive appointments, while cocoa cost pressures show signs of easing according to MarketBeat (July 1, 2026).
The outlook is mixed: analyst consensus targets $211.27 with 65.72% hold ratings, indicating cautious optimism amid valuation concerns. Key risks include commodity inflation and competitive pressures, but margin recovery and dividend yield near 3.2% offer potential for income-focused investors. Upside depends on sustained earnings growth and cost management.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AdaptHealth Corp
AdaptHealth provides patient-centered healthcare-at-home solutions in the U.S. It offers medical equipment and supplies for sleep therapy, respiratory health, diabetes management, and general home wellness.
Read more on AHCO →About Hershey Co
Hershey is a leading confectionery manufacturer in the U.S. (around a $25 billion market), controlling around 46% of the domestic chocolate space (per IRI). Beyond its namesake label, the firm's mix has expanded over the last 85 years and now consists of 100 brands, including Reese's, Kit Kat, Kisses, and Ice Breakers. Hershey's products are sold in about 80 countries, albeit with just a high-single-digit percentage of sales coming from markets outside the U.S., including Brazil, India, and Mexico. The firm has sought inorganic opportunities to extend its reach beyond its core confection business, adding Amplify Snack Brands and its Skinny Pop ready-to-eat popcorn to its mix and Pirate Brands (including the Pirate's Booty, Smart Puffs, and Original Tings brands) over the past few years.
Read more on HSY →
